This approach reflects the success seen with SGLT2 inhibitors, which have demonstrated significant cardioprotective and anti-inflammatory effects in conditions such as SLE, leading to their integration into clinical practice for autoimmune diseases (83)
As the first FDA-approved oral GLP-1 for weight management, it achieves comparable success to its injectable counterpart
AMG 133 (maridebart cafraglutide) is a bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR antagonist antibody to two GLP-1 analogue agonist peptides using amino acid linkers
Achieving effective, long-term weight loss can enhance more than just your physical appearance
10.1016/j.celrep.2019.10.128 131 SunZ.YuanX.WuJ.WangC.ZhangK.ZhangL.et al (2023)
At NextMed Clinic, our doctors provide a personalised weight loss program, helping you decide whether Mounjaro or Ozempic is the right treatment for you